News

Press Releases

1. Heidelberg, November 6, 2025

   FDA Greenlights Pivotal Study of PRECISIS’ Minimally Invasive Brain-Stimulation Therapy for Drug-Resistant Epilepsy

   PRECISIS GmbH today announced that the U.S. Food & Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for its pivotal EASEE4US clinical study, ma […]

   Read more
2. Heidelberg, October 30, 2025

   European Investment Bank backs German MedTech: €20 million for PRECISIS

   The European Investment Bank (EIB) is providing PRECISIS GmbH with a venture loan of €20 million.

   Read more
3. Padova, September 17, 2025

   First EASEE® Patient in Italy Successfully Implanted

   At Azienda Ospedale-Università of Padova, a patient in Italy has received the EASEE® system for the first time. The procedure was performed by neurosurgeon Prof. Andrea Landi in cl […]

   Read more
4. Heidelberg, September 5, 2025

   150 Patients – 150 Times New Hope

   We at PRECISIS are proud to announce a major milestone: 150 patients implanted with EASEE® across Europe.

   Read more
5. Heidelberg, July 1, 2025

   Precisis focuses on international growth: Steven Griffiths appointed VP European Sales

   Precisis, the Heidelberg-based MedTech company specializing in neuromodulation, has appointed Steven Griffiths as Vice President European Sales

   Read more
6. Heidelberg, May 22, 2025

   Two Years, Real Results: EASEE® Therapy Brings Lasting Relief to People with Drug-Resistant Epilepsy

   For people living with drug-resistant epilepsies, every day can feel uncertain. But a newly published long-term study offers a powerful message of hope: our EASEE® system has demon […]

   Read more
7. Newcastle, May 2, 2025

   First UK Patient Received Revolutionary EASEE® Implant

   Precisis is proud to announce a significant milestone in epilepsy treatment with the first UK patient undergoing surgery to fit the revolutionary EASEE® implant at the Royal Infirm […]

   Read more
8. Heidelberg, October 17, 2024

   EASEE® System Successfully Implanted at Coimbra University Hospital

   We are proud to announce a significant advancement in epilepsy treatment with the first successful implantation of our EASEE® epilepsy system at Coimbra University Hospital in Port […]

   Read more
9. Heidelberg, October 16, 2024

   Precisis Celebrates Second Place at the HEALTH-i Award 2024

   We are thrilled to announce that Precisis has achieved second place at the prestigious HEALTH-i Award 2024, a significant milestone in our journey towards revolutionizing epilepsy […]

   Read more
10. Berlin, September 13, 2024

    PEARL Study Initiated to Assess the Long-Term Effects of the EASEE® Brain Stimulator – 135 People with Epilepsy* Can Participate

    Technological devices that deliver electrical pulses to nerve tissue—known as neurostimulation therapies—have already helped many people alleviate chronic pain. Many Parkinson's pa […]

    Read more